Pharma Journalist -

Regeneron Pharmaceuticals and Sanofi announced that Praluent (alirocumab) will be made available at a new reduced U.S. list price of $5,850annually, a 60% reduction from the original…
Read More...

The Epilepsy Society and UCB, a global biopharmaceutical company headquartered in Belgium, with a significant UK R&D hub in Slough, UK, have announced an exciting new collaboration…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drug Advisory Committee and Drug Safety and…
Read More...

RegeneRx Biopharmaceuticals announced that ReGenTree, LLC, a joint venture between GtreeBNT and RegeneRx, has executed an agreement with Ora, Inc., located in Andover, Massachusetts,…
Read More...

Discover the future of clinical development at Adaptive Designs in Clinical Trials Conference 2019 SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials…
Read More...

Eton Pharmaceuticals, Inc. announced that it has entered into an exclusive licensing and supply agreement with Sintetica SA, a Swiss-based pharmaceutical company, to obtain U.S.…
Read More...

WuXi Biologics and Amicus Therapeutics announced that the companies have entered into an exclusive commercial manufacturing partnership for Amicus' Pompe biologic ATB200. Per the…
Read More...

3SBio Inc. and Verseau Therapeutics, Inc. announced a partnership agreement focused on the development and commercialization of novel monoclonal antibodies in the field of…
Read More...

Moberg Pharma AB has signed an exclusive license agreement with Bayer for commercialization of MOB-015 in Europe. Under the agreement, Moberg Pharma is eligible to receive up to EUR 50…
Read More...

Latest Developments in Combating Antifungal Resistance to be discussed by Industry Leaders at Superbugs & Superdrugs Conference in London SMi Reports: Superbugs & Superdrugs…
Read More...